What is Victoza?
What is Victoza?
The last 10 years has seen a growth in Type 2 diabetes treatments – and a rise in serious and sometimes life-threatening side effects. News of acute pancreatitis’ link to the drug Victoza has spurred the public question: What is Victoza?
Victoza is an injectable medication for the treatment of Type 2 diabetes, made and marketed by the Danish pharmaceutical company Novo Nordisk®. It comes in the form of prefilled needles that are taken once a day. Victoza is not insulin and is recommended for use in conjunction with a healthy diet and regular exercise.
Victoza helps the pancreas release the right amount of insulin to help sugar enter the body’s cells and prevents the liver from releasing too much sugar. Normally, these functions are taken care of by the hormone GLP-1, which occurs naturally in the human body. People with Type 2 diabetes, however, produce less insulin and may have problems with the GLP-1 hormone.
- It is not known if Victoza is safe and effective when used with prandial insulin
- Victoza is not for use in people with type 1 diabetes or people with diabetic ketoacidosis
- Victoza is not recommended for use in children
Patients who take Victoza and have a history of pancreatitis, gallstones, alcoholism, or high blood triglyceride levels could be at higher risk of developing pancreatitis.
Victoza Side Effects
Victoza was controversial prior to its official release in 2010. In early clinical trials, it was discovered that pancreatitis occurred more frequently among patients who took Victoza. It was also discovered that high doses of Victoza caused thyroid tumors and thyroid cancer among rats, although it was unknown whether it would have the same effect on humans.
In 2011, the FDA issued a public health warning of Victoza side effects and the link to thyroid cancer. Later that year, the FDA issued another warning, cautioning the public about Victoza’s link to kidney dysfunction.
In 2012, Public Citizen, a public health advocacy group, requested that the FDA remove the drug from the market, citing Victoza side effects such as the increased the risk of thyroid cancer, pancreatitis, serious allergic reactions and kidney failure. Public Citizen alleged that patients who take Victoza are four times more likely to develop acute pancreatitis than patients who take other Type 2 medications.
In March, 2013, the FDA announced the results of a study that showed an increased risk of pancreatic cancer and pancreatitis among patients who take Victoza and other Type 2 diabetes treatments.
The most common Victoza side effects include:
If you experience any of these Victoza side effects, it is critical to see your doctor right away.
Victoza is one of the most popular Type 2 diabetes treatments in the world. Novo Nordisk estimates that Victoza has 58 percent of the market share for GLP-1 diabetes treatments, with sales of the drug rising 38 percent in the first quarter of 2013.
When Public Citizen launched its demand to have Victoza taken off the market by the FDA, the advocacy group alleged that the FDA approved Victoza in spite of recommendations by three of its clinical safety advisors.
The latest warning by the FDA, linking Victoza to pancreatitis and pancreatic cancer, has spurred thousands of patients to seek legal help.
If you are taking Victoza and have been diagnosed with pancreatitis, pancreatic cancer, thyroid cancer or kidney disease, you could file a Victoza lawsuit to get financial compensation for:
- Current and future medical expenses
- Current and future lost wages
- Medical expenses not covered by insurance
- Emotional suffering
- Loss of consortium (future family benefits)
Call now for your free Victoza legal consultation. In just 10 minutes, you could find out if you have a Victoza lawsuit. 1-800-THE-LAW2.